Shukra Pharmaceuticals (BOM:524632) EBIT per Share : ₹4.68 (TTM As of Jun. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Shukra Pharmaceuticals EBIT per Share?

Shukra Pharmaceuticals's EBIT per Share for the three months ended in Jun. 2024 was ₹0.20. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 was ₹4.68.

During the past 12 months, the average EBIT per Share Growth Rate of Shukra Pharmaceuticals was 92.00% per year. During the past 3 years, the average EBIT per Share Growth Rate was 268.80% per year. During the past 5 years, the average EBIT per Share Growth Rate was 146.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Shukra Pharmaceuticals's EBIT per Share or its related term are showing as below:

BOM:524632' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -60.2 Med: 43.05 Max: 375.1
Current: 268.8

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Shukra Pharmaceuticals was 375.10% per year. The lowest was -60.20% per year. And the median was 43.05% per year.

BOM:524632's 3-Year EBIT Growth Rate is ranked better than
99.65% of 848 companies
in the Drug Manufacturers industry
Industry Median: 7.25 vs BOM:524632: 268.80

Shukra Pharmaceuticals's EBIT for the three months ended in Jun. 2024 was ₹8.6 Mil.

Shukra Pharmaceuticals EBIT per Share Historical Data

The historical data trend for Shukra Pharmaceuticals's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shukra Pharmaceuticals EBIT per Share Chart

Shukra Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT per Share

Get a 7-Day Free Trial

0.02

0.04

2.07

3.02

4.61

Shukra Pharmaceuticals Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
EBIT per Share	Get a 7-Day Free Trial															0.33	1.09	2.19	1.21	0.20

Shukra Pharmaceuticals EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Shukra Pharmaceuticals's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

	EBIT per Share		(A: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	201.683	/	43.797
=	4.60

Shukra Pharmaceuticals's EBIT per Share for the quarter that ended in Jun. 2024 is calculated as

	EBIT per Share		(Q: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	8.584	/	44.118
=	0.19

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4.68

Shukra Pharmaceuticals (BOM:524632) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Shukra Pharmaceuticals EBIT per Share Related Terms

Thank you for viewing the detailed overview of Shukra Pharmaceuticals's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Shukra Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shukra Pharmaceuticals Ltd (BOM:524632) » Definitions » EBIT per Share

Traded in Other Exchanges

N/A

Address

Judges Bunglow Road, Bodakdev, 3rd Floor, Veer House, Opposite WIAA Office, Ahmedabad, GJ, IND, 380054

Website

https://www.shukrapharmaceuticals.com

Shukra Pharmaceuticals Ltd is engaged in the business of manufacturing and trading pharmaceutical products. The company markets its products in India and international markets. The company has two operating segments; pharmaceutical and Laboratory. Its product portfolio includes antibiotics, antibiotics, quinolones, macrolides, anti-bacterial, anti-fungal, anti-malarial, anti-viral, antiprotozoal, anti-anthelmintic, anti-depressant, anti-manic, anti-emetic, beta-blockers, analgesic, muscle relaxants, anti-tuberculosis, vitamin products, anti-allergic, corticosteroids, hyper and hypoglycemic, and others. It exports its products to Australia, Uganda, Kenya, the United Kingdom, Sri Lanka, Mauritius, and the Republic of Yemen.

Shukra Pharmaceuticals Headlines

No Headlines